Pain medicine, cannabis, ketamine and psilocybin in focus | #ASM24BRIS

"TopMedTalk Down Under" continues our 'as live' coverage of the 2024 Australian and New Zealand College of Anaesthetists (ANZCA) and Faculty of Pain Medicine's Annual Scientific Meeting. A frank conversation about the consequences surrounding relatively new legislation surrounding cannabis; how does recreational use interfere with anaesthesia? Further, how should ketamine be used in safe doses and can some of its effects be problematic? Also we discuss the momentum behind the currently unproductive drive to use psilocybin as a pain medicine. The discussion then moves to the significance of mental and psychological preparation for patients anticipating surgical events. Presented by Andy Cumpstey, Clinical lecturer, University Hospital Southampton NHS Foundation Trust and the University of Southampton, England, and Kate Leslie, Professor, Specialist Anaesthetist and Head of Research at the Royal Melbourne Hospital and the University of Melbourne with their guests Vivanne Tawfik, Associate Professor, Stanford University, California and Hance Clarke Staff Anesthesiologist, Toronto  General and Associate Professor, University of Toronto.